These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6129905)

  • 21. Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment.
    Ebstein RP; Biederman J; Rimon R; Zohar J; Belmaker RH
    Psychopharmacology (Berl); 1976 Dec; 51(1):71-4. PubMed ID: 13448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher cerebrospinal fluid angiotensin-converting enzyme levels in neuroleptic-treated than in drug-free patients with schizophrenia.
    Wahlbeck K; Ahokas A; Miettinen K; Nikkilä H; Rimón R
    Schizophr Bull; 1998; 24(3):391-7. PubMed ID: 9718631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype.
    Garver DL; Tamas RL; Holcomb JA
    Neuropsychopharmacology; 2003 Aug; 28(8):1515-20. PubMed ID: 12799618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased CSF cortisol levels after neuroleptic treatment in schizophrenia.
    Gattaz WF; Hannak D; Beckmann H
    Psychoneuroendocrinology; 1985; 10(3):351-4. PubMed ID: 2865767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A longitudinal study of cerebrospinal fluid angiotensin-converting enzyme in neuroleptic-treated schizophrenia.
    Wahlbeck K; Ahokas A; Nikkilä H; Miettinen K; Rimón R
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 May; 21(4):591-9. PubMed ID: 9194142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In-patient withdrawal treatment of heroin addicts with neuroleptics (author's transl)].
    Schanda H; Presslich O; Hermann P; Walcher R
    Wien Klin Wochenschr; 1982 Jan; 94(2):43-8. PubMed ID: 6123195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptics reduce spinal fluid cyclic AMP in schizophrenic patient.
    Biederman J; Rimon R; Ebstein R; Zohar J; Belmaker R
    Neuropsychobiology; 1976; 2(5-6):324-7. PubMed ID: 197445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H; Reynolds GP; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz WF
    Arch Psychiatr Nervenkr (1970); 1983; 232(6):463-71. PubMed ID: 6134517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid inositol monophosphatase: elevated activity in depression and neuroleptic-treated schizophrenia.
    Atack JR; Levine J; Belmaker RH
    Biol Psychiatry; 1998 Sep; 44(6):433-7. PubMed ID: 9777174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of cerebrospinal fluid glutamic acid in Huntington's chorea and in schizophrenic patients.
    Kim JS; Kornhuber HH; Holzmüller B; Schmid-Burgk W; Mergner T; Krzepinski G
    Arch Psychiatr Nervenkr (1970); 1980; 228(1):7-10. PubMed ID: 6104477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics.
    Herrán A; García-Unzueta MT; Fernández-González MD; Vázquez-Barquero JL; Alvarez C; Amado JA
    Psychiatry Res; 2000 Apr; 94(1):51-8. PubMed ID: 10788677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients.
    Heikkilä L; Rimón R; Terenius L
    Psychiatry Res; 1990 Dec; 34(3):229-36. PubMed ID: 1706098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced CSF neurotensin concentration in drug-free schizophrenic patients.
    Lindström LH; Widerlöv E; Bisette G; Nemeroff C
    Schizophr Res; 1988; 1(1):55-9. PubMed ID: 3154507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia.
    Schwarz MJ; Ackenheil M; Riedel M; Müller N
    Neurosci Lett; 1998 Sep; 253(3):201-3. PubMed ID: 9792246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease of CSF dopamine, its metabolites and noradrenalin after withdrawal of chronic neuroleptic treatment in schizophrenic patients.
    Bagdy G; Perényi A; Arató M; Rotstein E
    Psychiatry Res; 1984 Jun; 12(2):177-8. PubMed ID: 6147870
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood zinc level in the course of HIV infection in drug addicts].
    Isa L; Lucchini A; Venezia R; Strepparola G; Giachetti M; Pissaia L; Galli G
    Recenti Prog Med; 1988 Dec; 79(12):500-2. PubMed ID: 3241901
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cerebrospinal fluid sorption in patients with heroin addiction].
    Mikhaĭlova NG; Reshchikov AM; Tokalov SV; Khanson KP; Kornilov NV; Iagunov AS; Chukhlovin AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(6):32-4. PubMed ID: 9677695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF N-CAM in neuroleptic-naïve first-episode patients with schizophrenia.
    Vawter MP; Hemperly JJ; Freed WJ; Garver DL
    Schizophr Res; 1998 Nov; 34(3):123-31. PubMed ID: 9850978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.
    Kim JS; Kornhuber HH; Schmid-Burgk W; Holzmüller B
    Neurosci Lett; 1980 Dec; 20(3):379-82. PubMed ID: 6108541
    [No Abstract]   [Full Text] [Related]  

  • 40. Disturbances in cell recognition molecules (N-CAM and L1 antigen) in the CSF of patients with schizophrenia.
    Poltorak M; Khoja I; Hemperly JJ; Williams JR; el-Mallakh R; Freed WJ
    Exp Neurol; 1995 Feb; 131(2):266-72. PubMed ID: 7895825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.